Investors in Ar

BLQ, or Building Legacy Quota, is a tech fund based in Stockholm, Sweden, dedicated to investing in early-stage tech companies navigating the challenging "valley of death" phase. Their mission is to build a lasting legacy by refining and supporting these companies methodically, aiming for profitability and sustained impact long into the future.

Founded in 2014, we are a prominent fintech investor in Northern Europe and a founding member of the Swedish FinTech Association. Specializing in early-stage investments, we focus on unlisted companies and actively assist them in implementing strong business processes. With a portfolio of over 40 companies across fintech and related sectors like e-commerce and insurtech, we support startups with scalable concepts and dedicated teams across Northern European markets from our offices in Stockholm and Helsinki.

Flerie is a proactive, long-term investor in the life sciences sector, specializing in biotech and pharmaceutical investments on a global scale. Headquartered in Stockholm and London, Flerie oversees a diverse portfolio of more than 30 investments spanning across Europe, Israel, and the US. Their mission is to empower innovative organizations primarily in drug development and related services, offering essential resources and expertise to foster success. Flerie manages assets totaling over SEK 3,000 million across three distinct segments: Product Development, Commercial Growth, and Limited Partnerships.

Their commitments to founders are straightforward and supportive: They pledge to provide backing and support, allowing entrepreneurs the autonomy to manage their businesses. They emphasize their role as genuinely long-term investors, with no obligations to demand returns within specific timeframes. They stand ready to offer assistance whenever founders seek their guidance or support. Moreover, they acknowledge that mistakes are a natural part of business growth but stress the importance of learning from them for continuous improvement.

They strive to expand access to capital beyond traditional boundaries. Their focus lies in investing in rapidly expanding and profitable European enterprises. Acting as proactive stakeholders, they facilitate connections with robust capital markets, fostering mutual growth and development.

Wellstreet Ventures' Ventures II Fund continues their successful approach from their first fund, targeting early-stage startups in D2C, B2B, SaaS, and product sectors. They prioritize diverse founders with strong commercial acumen and a growth mindset. Key investment criteria include enhancing customer experience, utilizing data-driven models, and adhering to proactive ESG standards. They focus on startups poised for mainstream adoption, ensuring strategic early-stage investments.

Schibsted Marketplaces, renowned for its leading brands in the Nordics, is reshaping consumer consumption patterns across goods and services. Recently, the company underwent a split into two distinct entities. Concerning the division, their business focuses on developing marketplaces within four primary sectors – Mobility, Recommerce, Real Estate, and Jobs – pivotal elements within the circular economy.

HealthCap is a European venture capital firm investing globally in life sciences and has raised eight funds since 1996. HealthCap has backed and built more than 127 companies, taken more than 45 companies public, and completed numerous trade sales. The investment strategy focuses on diseases with a high unmet medical need and breakthrough therapies that have the potential to be transformative, change clinical practice, and change the lives of patients suffering from these conditions.

SEB Venture Capital, a leading Fintech investor in the Nordics since 1995, aims to create sustainable, long-term value through strategic investments in innovative companies. They prioritize strong management teams and seek transformative technologies that enhance the financial industry's intelligence, safety, sustainability, and user experience. Their partnerships offer access to extensive international networks, specialized expertise, and robust financial resources within SEB.

They support entrepreneurs who are developing solutions for the AI era, focusing on founders creating technically sophisticated data and AI tools, as well as AI-native applications. Above all, they prioritize founders who demonstrate exceptional creativity, insatiable curiosity, and unwavering determination to succeed.

Luminar is the most active pre-seed and seed-stage VC fund in Sweden. Their focus now extends globally as they seek out future-forward technologies and business models, supporting top-tier founders primarily in the Nordic region.

Creandum, founded after the dotcom bubble and having thrived through the 2008/9 economic crisis, continues to invest steadily despite recent market conditions, believing top founders can emerge anytime. They've witnessed significant growth in the European tech market over 20 years. Now, they proudly announce the closing of Creandum VII, a €500m fund to support Europe's top Seed and Series A startups. Their disciplined, generalist approach focuses on partnering with the best entrepreneurs to build future global, category-defining companies.